AZTAAzenta, Inc.Healthcare · Medical - Instruments & Suppliesas of 2026-09-16
Horizon

Issued 2026-09-16 at $33.21 · now $33.21 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, AZTA has typically landed between $25.85 and $40.34 — a range of −22.2% to +21.5% from the issuance price $33.21.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,003 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($33.21) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where AZTA has typically landed a month from the 2026-09-16 close of $33.21 — the range is history, not a prediction.

$25.85worst · -22.2%$40.34best · +21.5%
  • now $33.21 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $32.96 (-0.8%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $29.75–$36.16
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $25.85–$40.34
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,003 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2008-10-21−64.1%−64.1%+0.0%
2008-10-22−62.9%−62.9%+2.6%
2008-10-20−61.6%−61.6%+0.0%
3 best
2008-11-20+106.4%+0.0%+123.2%
2008-11-19+90.4%−6.9%+107.8%
2008-11-21+79.2%+0.0%+100.4%

5,003 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
55%
+2.3%
n=20
Feb
55%
−1.7%
n=20
Mar
55%
−1.1%
n=20
Apr
45%
+3.0%
n=20
May
50%
−1.1%
n=20
Jun
60%
+1.2%
n=20
Jul
50%
+3.1%
n=20
Aug
40%
−0.7%
n=20
Sep
50%
+0.4%
n=20
Oct
55%
+0.8%
n=20
Nov
65%
+6.0%
n=20
Dec
50%
+4.7%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$41$162026-07-31: 1 insider purchase, $8K — Starr Ephraim2026-05-18: 1 insider purchase, $164K — Cornog William L2025-09-10: 1 insider sale, $9K — Marotta John2025-08: 1 open-market purchase, $70K2025-09: 1 open-market sale, $9K2026-05: 1 open-market purchase, $164K2026-07: 1 open-market purchase, $8K↑ buys↓ salesofficer Starr Ephraim — Purchase on 2026-07-31, filed 4 days after the tradedirector Cornog William L — Purchase on 2026-05-18, filed 1 day after the tradedirector Marotta John — Sale on 2025-09-10, filed 2 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-07-31Starr EphraimofficerPurchase335 @ $24.17$8K+0.5% of holding+13.4%not yet — horizon still open68,728Form 4 · filed 4 days after the trade
2026-05-18Cornog William LdirectorPurchase10,000 @ $16.38$164K+103.1% of holding+39.3%not yet — horizon still open19,703Form 4 · filed 1 day after the trade
2025-09-10Marotta JohndirectorSale316 @ $29.41$9K−0.3% of holding+5.2%−29.7%105,980Form 4 · filed 2 days after the trade
2025-08-11Lin Lawrence Y.officerPurchase2,500 @ $27.96$70K+5.7% of holding+2.1%−2.3%46,013Form 4 · filed 1 day after the trade
2025-02-03Hughes ViolettaofficerSale317 @ $52.97$17K−3.2% of holding−18.9%−54.0%9,603Form 4 · filed 1 day after the trade
2025-01-31Zhou GingerofficerPurchase417 @ $45.88$19K+1.5% of holding−19.9%−45.5%27,916Form 4 · filed 4 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

56 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-15Bello Erik J.officerAward / grant4,5864,586Form 4
2026-09-14Starr EphraimofficerAward / grant15,27284,000Form 4
2026-09-14Madaus Martin DdirectorAward / grant36,65344,058Form 4
2026-09-14MARTIN WILLIAM E. IIIofficerAward / grant15,27233,062Form 4
2026-09-14Pirogova OlgaofficerAward / grant15,27247,225Form 4
2026-09-14Lin Lawrence Y.officerAward / grant30,544110,199Form 4
2026-08-09Pirogova OlgaofficerWithheld for tax1,08531,953Form 4
2026-05-15Starr EphraimofficerWithheld for tax3,62168,393Form 4
2026-04-28MARTIN WILLIAM E. IIIofficerAward / grant17,79017,790Form 4
2026-02-06Nova Tina SusandirectorAward / grant5,66315,772Form 4
2026-02-05Casal FrankdirectorAward / grant7,24321,803Form 4
2026-02-05McLaughlin EricadirectorAward / grant5,66322,521Form 4
2026-02-05Doshi DipaldirectorAward / grant5,6639,703Form 4
2026-02-05Koffey QuentindirectorAward / grant5,66310,698Form 4
2026-02-05Madaus Martin DdirectorAward / grant5,6639,703Form 4
2026-02-05Madaus Martin DdirectorAward / grant5,6639,703Form 4
2026-02-05Cornog William LdirectorAward / grant5,6635,663Form 4
2026-02-05Cornog William LdirectorAward / grant5,6635,663Form 4
2026-02-05Davis Robyn CdirectorAward / grant5,66323,662Form 4
2026-02-05Davis Robyn CdirectorAward / grant5,66323,662Form 4
2025-11-24Pirogova OlgaofficerAward / grant16,30333,038Form 4
2025-11-24Zhou GingerofficerAward / grant13,04238,755Form 4
2025-11-24Marotta JohndirectorAward / grant122,269217,269Form 4
2025-11-24Starr EphraimofficerAward / grant34,23572,014Form 4
2025-11-24Lin Lawrence Y.officerAward / grant36,68179,655Form 4
2025-11-14Marotta JohndirectorWithheld for tax10,98095,000Form 4
2025-11-14Lin Lawrence Y.officerWithheld for tax3,03942,974Form 4
2025-11-14Pirogova OlgaofficerWithheld for tax1,55316,735Form 4
2025-11-14Zhou GingerofficerWithheld for tax1,11825,713Form 4
2025-08-12Pirogova OlgaofficerDisposition1,08518,288Form 4
2025-08-12Zhou GingerofficerDisposition1,08526,831Form 4
2025-06-02Marotta JohndirectorAward / grant1,000107,296Form 4
2025-05-30Malus Alan JdirectorAward / grant12,00017,035Form 4
2025-05-20Cornog William LdirectorAward / grant2,74821,755Form 4
2025-05-19Cornog William LdirectorAward / grant4,15219,007Form 4
2025-05-16Cornog William LdirectorAward / grant10014,855Form 4
2025-05-15Starr EphraimofficerAward / grant37,77937,779Form 4
2025-05-09Lin Lawrence Y.officerAward / grant4,00043,513Form 4
2025-05-09Marotta JohndirectorAward / grant1,796106,296Form 4
2025-05-08Marotta JohndirectorAward / grant3,638102,658Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.